17505008 |
AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor
Fukuoka, K,
Yamada, Y,
Yanagihara, K,
Nishio, K,
Sasaki, H,
Kimura, H,
Takeda, M,
Tamura, T,
Komatsu, T,
Yokote, H,
Arao, T,
Saijo, N
|
Clin Cancer Res |
2007 |
9857065 |
Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation
Thompson, LM,
Raffioni, S,
Bradshaw, RA,
Zhu, YZ
|
J Biol Chem |
1998 |
18373495 |
Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling
Tregidgo, C,
Suhling, K,
Ladbury, JE,
Ahmed, Z,
Schüller, AC
|
Biochem J |
2008 |
19381019 |
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
Stephan, JP,
Dornan, D,
Stinson, S,
Wiesmann, C,
Du, X,
Wu, P,
Qing, J,
Ashkenazi, A,
Wu, Y,
Tien, J,
French, D,
Totpal, K,
Chan, P,
Chen, Y,
Marsters, S,
Ross, S,
Li, H,
Wang, QR,
Stawicki, S
|
J Clin Invest |
2009 |
21711248 |
Fibroblast growth factors and their receptors in cancer
Haglund, K,
Wesche, J,
Haugsten, EM
|
Biochem J |
2011 |
20094046 |
Fibroblast growth factor signalling: from development to cancer
Grose, RP,
Turner, N
|
Nat Rev Cancer |
2010 |
20709759 |
GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling
Poling, LL,
Bai, A,
Chen, T,
Vo, NY,
Gyuris, J,
Ismail, NS,
Jiang, J,
Weiler, S,
Weng, Z,
Winston, WM,
Kollipara, S,
Lerner, L,
Mazsa, EK,
Meetze, K
|
Cancer Res |
2010 |
21666749 |
Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Mermel, C,
Hammerman, PS,
Greulich, H,
Gray, NS,
Ramos, AH,
Cho, J,
Chande, A,
Dutt, A,
Tanaka, KE,
Stransky, N,
Meyerson, M,
Sharifnia, T
|
PLoS One |
2011 |